4//SEC Filing
WENDER JOSEPH H 4
Accession 0000874015-25-000288
CIK 0000874015other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 7:01 PM ET
Size
8.0 KB
Accession
0000874015-25-000288
Insider Transaction Report
Form 4
WENDER JOSEPH H
Director
Transactions
- Sale
Common Stock
2025-12-01$80.67/sh−20,571$1,659,362→ 43,464 total(indirect: By Trust) - Sale
Common Stock
2025-12-01$81.23/sh−7,429$603,486→ 36,035 total(indirect: By Trust)
Holdings
- 16,000
Common Stock
Footnotes (3)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 26, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.11 to $81.11 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.12 to $81.435 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001073384
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 7:01 PM ET
- Size
- 8.0 KB